Delivery Order SPE2DX22D0010-SPE2D825FHU55
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,782.29 to AmerisourceBergen Drug Corp for AZSTARYS 39.2 mg-7.8 mg capsules (100-count) on August 19, 2025, with completion scheduled for August 20, 2025. This contract represents a firm fixed price delivery order with no set-aside designation, issued competitively under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion pharmaceutical supply vehicle...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,210.98, is for the supply of AZSTARYS CAPS 39.2MG/7.8MG medical products. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- The Defense Logistics Agency Troop Support Medical awarded a $428,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561865437 AZSTARYS 52.3 MG-10.4 MG CAP 100S. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order has a period of performance starting on August 17, 2023 through August 18, 2023. No major subcontractors or set aside designations were indicated. The Defense Logistics Agency manages the...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AZSTARYS 39.2 MG-7.8 MG CAP 100S, a pharmaceutical product. The total ceiling value of the contract is $1,630.88, with a period of performance through June 11, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of AZSTARYS CAPS 39.2MG/7.8MG, a pharmaceutical product. The contract has a ceiling value of $1,537.26 and a period of performance through May 8, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
- This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of AZSTARYS 39.2 MG-7.8 MG CAP 100S, a pharmaceutical product. The contract has a firm fixed price of $1,493.44 and an ultimate completion date of May 30, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a for-profit organization headquartered in Conshohocken, Pennsylvania and...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $2,148.68 and is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that runs through November 2026. The IDC serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies, including...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain has awarded a delivery order valued at $1,780.60 to AmerisourceBergen Drug Corp (CAGE 0U9U0), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed price delivery order, awarded on August 2, 2025, with an ultimate completion date of August 4, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $108,554.87 to AmerisourceBergen Drug Corp on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded contract for pharmaceutical products and medical supplies. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $75,255.74 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This non-set-aside, competitively awarded contract represents a firm fixed price delivery order with an ultimate completion date of July 29, 2025. AmerisourceBergen Drug Corp will perform the contract at its corporate office location in Conshohocken, PA 19428. This delivery...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D825FHU55Delivery Order
The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $3,856.69 to AmerisourceBergen Drug Corp for AZSTARYS CAPS 39.2MG/7.8MG on August 20, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of August 21, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal medical procurement vendor with extensive experience supplying pharmaceuticals and medical supplies to military and veteran healthcare systems. The company's federal contract portfolio demonstrates consistent capability in delivering a comprehensive range of medications across multiple therapeutic domains. This delivery order for AZSTARYS, a pharmaceutical product, reflects the company's ongoing role in supporting the Defense Health Agency and other government healthcare systems through the DLA's pharmaceutical supply network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 8/20/25 |